arrow
N

Nicolas Boissel

Institut de recherche Saint-Louis
H指数:72
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Anti-thymocyte globulin triggers TNF-dependent cell death in T-cell acute lymphoblastic leukemia

抗胸腺细胞球蛋白触发T细胞急性淋巴细胞白血病中TNF依赖性细胞死亡

2026-09-190
OAAI
Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome
Leukemia
IF13.4
2026-08-310
OA
Genomic landscape of acute myeloid leukemia in adolescents and young adults

青少年和年轻成人急性髓系白血病的基因组景观

Leukemia
IF13.4
2026-06-250
PRE
Blinatumomab consolidation for high-risk Ph-negative B-cell acute lymphoblastic leukemia: the GRAALL-2014/B-QUEST study

Blinatumomab巩固治疗高风险Ph阴性B细胞急性淋巴细胞白血病:GRAALL-2014/B-QUEST研究

Blood
IF23.1
2026-04-280
PRE
Impact of stem cell source in HLA-matched hematopoietic stem cell transplant for acute lymphoblastic leukemia in first complete remission: a study from the GRAALL and the SFGM-TC

HLA匹配造血干细胞移植中干细胞来源对首次完全缓解急性淋巴细胞白血病的影响:GRAALL和SFGM-TC的研究

2026-04-160
PRE
Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia

核心结合因子急性髓系白血病中的基因改变和可测量残留疾病

Leukemia
IF13.4
2026-03-260
PRE
Characteristics and outcome determinants in children, adolescents and young adults who failed tisagenlecleucel for B-cell acute lymphoblastic leukemia

tisagenlecleucel治疗失败后,儿童、青少年和年轻成人B细胞急性淋巴细胞白血病的特征与结局决定因素

Leukemia
IF13.4
2026-02-240
PRE
Homeodomain-driven oncogenic diversion to a γδTCR phenotype in T-cell Acute Lymphoblastic Leukemia

T细胞急性淋巴细胞白血病中同源域驱动的致癌转移至 γ δ tcr表型

Blood
IF23.1
2026-01-290
PRE
Age‐adapted chemotherapy and MRD‐oriented transplant for Ph-negative acute lymphoblastic leukemia - GRAALL-2014 trial

年龄适应化疗和微小残留病导向移植治疗Ph阴性急性淋巴细胞白血病——GRAALL-2014试验

Blood
IF23.1
2025-10-280
PRE
Predicting cardiovascular events in allogeneic haematopoietic stem cell transplant recipients

预测异基因造血干细胞移植受者的心血管事件

2025-10-010
PRE
Early administration of selected CD34 peripheral blood stem cell following bone marrow transplantation to prevent graft rejection: experience in haploidentical transplant for sickle cell disease

在骨髓移植后早期输注选择性CD34阳性外周血干细胞以预防移植物排斥:在半相合移植治疗镰状细胞病中的经验

2025-09-120
PRE
LEF1 intragenic deletion induces a dominant-negative isoform and unveils a Wnt/β3-catenin vulnerability in T-ALL

LEF1基因内缺失诱导产生显性负效异构体,并揭示T-ALL中Wnt/β3-连环蛋白的易损性。

Blood
IF23.1
2025-08-280
PRE
Towards methylation-based redefinition of TAL1 positive T-cell acute lymphoblastic leukaemia (T-ALL)

基于甲基化对TAL1阳性T细胞急性淋巴细胞白血病(T-ALL)的重新定义

Leukemia
IF13.4
2025-08-080
PRE
Asciminib for relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.

阿西米尼布用于费城染色体阳性复发性或难治性急性淋巴细胞白血病的治疗。

2025-07-040
OAAI
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies

I 期/II 期临床试验:评估抗CD7 异基因 WU-CART-007 在复发/难治性 T 细胞恶性肿瘤患者中的疗效

Blood
IF23.1
2025-06-020
PRE